We back early-stage ventures that leverage data and AI technologies to advance biotech and health sciences aiming for social impact.
Impact | Innovate | Invest
​We enable the social impact by both developing in-house ventures and partnering with visionary entrepreneurs who share our mission to foster a more equitable and sustainable world. We empower these founders with the resources, expertise, and network necessary to rapidly test ideas and bring innovative solutions to the market. Our support extends across North America, from pre-Seed and Seed to Series A stages.
Precision Medicine
-
Advance biomedicine by leveraging AI technologies
-
Streamline drug discovery for rare diseases, advancing cell and gene therapy, optimizing vaccine development, digitalizing biomanufacturing process, addressing data biases in clinical trials
Climate-Monitoring Biodiversity
Amplify biodiversity efforts with data analytics by enabling precise genetic mutations surveillance in regions like Amazon and ecosystem affected by events such as the Fukushima radioactive water discharge
Customized Healthcare
-
Provide support for underserved communities in mental health with GenAI technologies, to feel safe and secure anytime
-
Personalized healthcare delivery for culture and language experience
Public-private Partnership
Tech policy and collective efforts across borders are vital in guiding tech utilization at the global scale, ensuring the grasp of potential, limitations and ethical implications of emerging technologies such as AI and biotech
Our Approach
01.
Identify Market Opportunities within Verticals
02.
Develop In-house Ventures or Find the Right Founder to Partner
03.
Analyze the Specific Opportunities and Strategize Roadmap
04.
Iterate Team and Minimal Viable Product for Quick Testing
05.
Pre-incorporation and Invest
Insights
Founder's Story
“While science exists in a realm of inherent neutrality, technology is invariably shaped by market demands. This distinction has precipitated current challenges—health inequities and a pervasive digital divide disproportionately affecting minorities, women, people of color, and individuals from lower socioeconomic backgrounds. The rapid advancement of AI and biotech has not only introduced new dimensions of digital segregation, more complex and far-reaching than geographic disparities, but also disrupted traditional markets and societal norms, catalyzing issues of resource inequality and environmental degradation. “
—— Founder & CEO, Linxin Gu
